National Institute of Health 2021
Global Vitiligo Foundation Listing.
For Vitiligo patients age 12 years and older,
This is Incyte trial for Ruxolitinib cream and is recommended for those with less than 10% vitiligo on the body.
https://clinicaltrials.gov/ct2/show/NCT04052425
Vitiligo Clinic and Research Center - Dr. John Harris